{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T07:46:57Z","timestamp":1794901617370,"version":"4.9.1"},"reference-count":73,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1136\/bjophthalmol-2015-307722","type":"journal-article","created":{"date-parts":[[2015,12,24]],"date-time":"2015-12-24T01:48:05Z","timestamp":1450921685000},"page":"446-452","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":65,"title":["Endophthalmitis caused by Gram-positive organisms with reduced vancomycin susceptibility: literature review and options for treatment"],"prefix":"10.1136","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7815-0119","authenticated-orcid":false,"given":"Nidhi","family":"Relhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2199-9047","authenticated-orcid":false,"given":"Thomas A","family":"Albini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avinash","family":"Pathengay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2824-3245","authenticated-orcid":false,"given":"Ajay E","family":"Kuriyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4756-2030","authenticated-orcid":false,"given":"Darlene","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry W","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2015,12,23]]},"reference":[{"key":"key-10.1136\/bjophthalmol-2015-307722-1","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0161-6420(83)34511-5","article-title":"Results in the treatment of postoperative endophthalmitis","volume":"90","author":"Olson","year":"1983","journal-title":"Ophthalmology"},{"issue":"(Suppl 1)","key":"key-10.1136\/bjophthalmol-2015-307722-2","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1086\/491709","article-title":"Vancomycin: a history","volume":"42","author":"Levine","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key-10.1136\/bjophthalmol-2015-307722-3","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1755-3768.1975.tb01162.x","article-title":"Intravitreal injection of vancomycin in experimental staphylococcal endophthalmitis","volume":"53","author":"Homer","year":"1975","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"key-10.1136\/bjophthalmol-2015-307722-4","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0161-6420(88)32990-8","article-title":"Coagulase-negative staphylococcal endophthalmitis. Increase in antimicrobial resistance","volume":"95","author":"Davis","year":"1988","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2015-307722-5","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1097\/IAE.0b013e31829f742c","article-title":"Compounding bevacizumab for intravitreal injection: does USP <797> always apply?","volume":"33","author":"Shienbaum","year":"2013","journal-title":"Retina (Philadelphia, Pa)"},{"key":"key-10.1136\/bjophthalmol-2015-307722-6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9394(14)71959-2","article-title":"Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study","volume":"122","author":"Han","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307722-7","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ajo.2011.03.010","article-title":"Monitoring antibiotic resistance in ocular microorganisms: results from the Antibiotic Resistance Monitoring in Ocular micRorganisms (ARMOR) 2009 surveillance study","volume":"152","author":"Haas","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307722-8","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.ajo.2013.12.026","article-title":"Endophthalmitis caused by streptococcal species: clinical settings, microbiology, management, and outcomes","volume":"157","author":"Kuriyan","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307722-9","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/IAE.0b013e31818eccc7","article-title":"Endophthalmitis caused by Enterococcus faecalis: a case series","volume":"29","author":"Rishi","year":"2009","journal-title":"Retina"},{"key":"key-10.1136\/bjophthalmol-2015-307722-10","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/sj.eye.6701397","article-title":"Leuconostoc mesenteroids as a cause of post-operative endophthalmitis--a case report","volume":"18","author":"Kumudhan","year":"2004","journal-title":"Eye (Lond)"},{"key":"key-10.1136\/bjophthalmol-2015-307722-11","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1442-9071.2008.01890.x","article-title":"Chronic postoperative endophthalmitis with isolation of Leuconostoc and Olsenella uli in an Indigenous man","volume":"36","author":"Durkin","year":"2008","journal-title":"Clin Experiment Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307722-12","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1001\/archophthalmol.2010.77","article-title":"Vancomycin-resistant enterococcal endophthalmitis","volume":"128","author":"Sharma","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307722-13","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/j.jcrs.2011.07.023","article-title":"Vancomycin-resistant coagulase negative Staphylococcus endophthalmitis following cataract surgery","volume":"37","author":"Das","year":"2011","journal-title":"J Cataract Refract Surg"},{"key":"key-10.1136\/bjophthalmol-2015-307722-14","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1752-1947-5-130","article-title":"Quinupristin\/dalfopristin in Staphylococcus aureus endophthalmitis: a case report","volume":"5","author":"Hernandez-Da Mota","year":"2011","journal-title":"J Med Case Rep"},{"key":"key-10.1136\/bjophthalmol-2015-307722-15","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1001\/archophthalmol.2012.1504","article-title":"Quinupristin\/dalfopristin in vancomycin-resistant Staphylococcus aureus endophthalmitis","volume":"130","author":"Stroh","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307722-16","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1869-5760-3-46","article-title":"Vancomycin-resistant Gram-positive bacterial endophthalmitis: epidemiology, treatment options, and outcomes","volume":"3","author":"Khera","year":"2013","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"key-10.1136\/bjophthalmol-2015-307722-17","first-page":"1193","article-title":"Vancomycin-resistant Staphylococcus hominis endophthalmitis following cataract surgery","volume":"7","author":"Won","year":"2013","journal-title":"Clin Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307722-18","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1001\/archopht.125.9.1292","article-title":"Postoperative vancomycin-resistant Enterococcus faecium endophthalmitis","volume":"125","author":"Bains","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307722-19","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1159\/000344006","article-title":"Delayed-onset post-keratoplasty endophthalmitis caused by vancomycin-resistant Enterococcus faecium","volume":"3","author":"Hernandez-Camarena","year":"2012","journal-title":"Case Rep Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307722-20","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3129\/i07-057","article-title":"Community-acquired bleb-related endophthalmitis caused by vancomycin-resistant enterococci","volume":"42","author":"Tang","year":"2007","journal-title":"Can J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307722-21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1869-5760-3-42","article-title":"Post-traumatic vancomycin-resistant enterococcal endophthalmitis","volume":"3","author":"Hillier","year":"2013","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"key-10.1136\/bjophthalmol-2015-307722-22","first-page":"1","article-title":"Leuconostoc as a cause of endophthalmitis post-intravitreal injection of ranibizumab","volume":"21","author":"Damasceno","year":"2015","journal-title":"Ocul Immunol Inflamm"},{"key":"key-10.1136\/bjophthalmol-2015-307722-23","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00006982-200302000-00024","article-title":"Endogenous endophthalmitis secondary to vancomycin-resistant enterococci infection","volume":"23","author":"Esmaeli","year":"2003","journal-title":"Retina"},{"key":"key-10.1136\/bjophthalmol-2015-307722-24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/ICB.0000000000000082","article-title":"Endogenous endophthalmitis due to clinically vancomycin-resistant Staphylococcus aureus","volume":"9","author":"Dedania","year":"2015","journal-title":"Retin Cases Brief Rep"},{"key":"key-10.1136\/bjophthalmol-2015-307722-25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12348-015-0039-y","article-title":"Bilateral endogenous endophthalmitis caused by vancomycin-resistant Staphylococcus epidermidis in a neonate","volume":"5","author":"Relhan","year":"2015","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"key-10.1136\/bjophthalmol-2015-307722-26","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(97)07324-8","article-title":"Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin","volume":"350","author":"Hiramatsu","year":"1997","journal-title":"Lancet"},{"key":"key-10.1136\/bjophthalmol-2015-307722-27","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ajo.2009.08.023","article-title":"Staphylococcus aureus endophthalmitis: antibiotic susceptibilities, methicillin resistance, and clinical outcomes","volume":"149","author":"Major","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307722-28","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.3201\/eid0911.030284","article-title":"Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients","volume":"9","author":"Weber","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"key-10.1136\/bjophthalmol-2015-307722-29","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1128\/JCM.23.1.100-103.1986","article-title":"Evaluation of teicoplanin and vancomycin disk susceptibility tests","volume":"23","author":"Barry","year":"1986","journal-title":"J Clin Microbiol"},{"key":"key-10.1136\/bjophthalmol-2015-307722-30","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/jac\/16.2.179","article-title":"In-vitro evaluation of cefpirome (HR 810), teicoplanin and four other antimicrobials against enterococci","volume":"16","author":"Chandrasekar","year":"1985","journal-title":"J Antimicrob Chemother"},{"key":"key-10.1136\/bjophthalmol-2015-307722-31","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1128\/CMR.3.3.280","article-title":"Resistance to vancomycin and teicoplanin: an emerging clinical problem","volume":"3","author":"Johnson","year":"1990","journal-title":"Clin Microbiol Rev"},{"key":"key-10.1136\/bjophthalmol-2015-307722-32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0140-6736(88)91037-9","article-title":"Vancomycin-resistant enterococci","volume":"1","author":"Uttley","year":"1988","journal-title":"Lancet"},{"key":"key-10.1136\/bjophthalmol-2015-307722-33","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJM198807213190307","article-title":"Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium","volume":"319","author":"Leclercq","year":"1988","journal-title":"N Engl J Med"},{"key":"key-10.1136\/bjophthalmol-2015-307722-34","first-page":"379","article-title":"Vancomycin-resistant Streptococcaceae from clinical material","volume":"267","author":"Lutticken","year":"1988","journal-title":"Zentralbl Bakteriol Mikrobiol Hyg A"},{"key":"key-10.1136\/bjophthalmol-2015-307722-35","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1128\/AAC.33.9.1588","article-title":"In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis","volume":"33","author":"Sahm","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.1136\/bjophthalmol-2015-307722-36","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1128\/JCM.29.10.2335-2337.1991","article-title":"Vancomycin susceptibility and identification of motile enterococci","volume":"29","author":"Vincent","year":"1991","journal-title":"J Clin Microbiol"},{"key":"key-10.1136\/bjophthalmol-2015-307722-37","first-page":"597","article-title":"Nosocomial enterococci resistant to vancomycin\u2014United States, 1989\u20131993","volume":"42","author":"Centers for Disease Control and Prevention (CDC)","year":"1993","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.1136\/bjophthalmol-2015-307722-38","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1053\/srin.2000.20945","article-title":"Vancomycin-resistant enterococci","volume":"15","author":"McGeer","year":"2000","journal-title":"Semin Respir Infect"},{"key":"key-10.1136\/bjophthalmol-2015-307722-39","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1093\/clinids\/23.6.1234","article-title":"Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality","volume":"23","author":"Edmond","year":"1996","journal-title":"Clin Infect Dis"},{"key":"key-10.1136\/bjophthalmol-2015-307722-40","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/archopht.123.3.341","article-title":"Changing trends in the microbiologic aspects of postcataract endophthalmitis","volume":"123","author":"Recchia","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307722-41","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.ajo.2007.12.026","article-title":"Endophthalmitis caused by Bacillus species","volume":"145","author":"Miller","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307722-42","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1869-5760-4-5","article-title":"Endophthalmitis after open globe injuries: changes in microbiological spectrum and isolate susceptibility patterns over 14 years","volume":"4","author":"Jindal","year":"2014","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"key-10.1136\/bjophthalmol-2015-307722-43","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0886-3350(13)80842-5","article-title":"Filters and antibiotics in irrigating solution for cataract surgery","volume":"17","author":"Gills","year":"1991","journal-title":"J Cataract Refract Surg"},{"key":"key-10.1136\/bjophthalmol-2015-307722-44","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1177\/1120672103013009-1007","article-title":"The effect of intraoperative antibiotics in irrigating solutions on aqueous humor contamination and endophthalmitis after phacoemulsification surgery","volume":"13","author":"Sobaci","year":"2003","journal-title":"Eur J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307722-45","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2147\/OPTH.S9546","article-title":"Intracameral vancomycin following cataract surgery: an eleven-year study","volume":"4","author":"Anijeet","year":"2010","journal-title":"Clin Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307722-46","first-page":"25758","article-title":"Preventing the spread of vancomycin resistance\u2014a report from the Hospital Infection Control Practices Advisory Committee prepared by the Subcommittee on Prevention and Control of Antimicrobial-Resistant Microorganisms in Hospitals; comment period and public meeting\u2014CDC. Notice","volume":"59","year":"1994","journal-title":"Fed Regist"},{"key":"key-10.1136\/bjophthalmol-2015-307722-47","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1056\/NEJM199404283301725","article-title":"Multiple-antibiotic-resistant pathogenic bacteria. A report on the Rockefeller University Workshop","volume":"330","author":"Tomasz","year":"1994","journal-title":"N Engl J Med"},{"key":"key-10.1136\/bjophthalmol-2015-307722-48","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0161-6420(96)30521-6","article-title":"Antibiotic supplementation of intraocular irrigating solutions. An in vitro model of antibacterial action","volume":"103","author":"Gritz","year":"1996","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2015-307722-49","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.2147\/OPTH.S44212","article-title":"Intravitreal moxifloxacin in the management of Ochrobactrum intermedium endophthalmitis due to metallic intraocular foreign body","volume":"7","author":"Jacobs","year":"2013","journal-title":"Clin Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307722-50","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1128\/CMR.00042-09","article-title":"Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications","volume":"23","author":"Howden","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"key-10.1136\/bjophthalmol-2015-307722-51","volume-title":"Performance standards for antimicrobial susceptibility testing; 16th informational supplement","author":"Clinical and Laboratory Standards Institute","year":"2006"},{"key":"key-10.1136\/bjophthalmol-2015-307722-52","volume-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","author":"Clinical and Laboratory Standards Institute","year":"2009"},{"key":"key-10.1136\/bjophthalmol-2015-307722-53","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.idc.2009.06.010","article-title":"Antibiotics for gram-positive bacterial infections: vancomycin, teicoplanin, quinupristin\/dalfopristin, oxazolidinones, daptomycin, dalbavancin, and telavancin","volume":"23","author":"Nailor","year":"2009","journal-title":"Infect Dis Clin North Am"},{"key":"key-10.1136\/bjophthalmol-2015-307722-54","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.ophtha.2003.09.042","article-title":"Aqueous and vitreous penetration of linezolid (Zyvox) after oral administration","volume":"111","author":"Fiscella","year":"2004","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2015-307722-55","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1167\/iovs.09-4244","article-title":"The safety of intraocular linezolid in rabbits","volume":"51","author":"Duke","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2015-307722-56","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jcrs.2009.09.036","article-title":"Ocular penetration of topically applied linezolid in a rabbit model","volume":"36","author":"Saleh","year":"2010","journal-title":"J Cataract Refract Surg"},{"key":"key-10.1136\/bjophthalmol-2015-307722-57","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1167\/iovs.09-4638","article-title":"Minimum inhibitory concentrations of standard and novel antimicrobials for isolates from bacterial keratitis","volume":"51","author":"Sueke","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2015-307722-58","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2165\/00003495-199600511-00007","article-title":"Antibacterial activity of quinupristin dalfopristin\u2014rationale for clinical use","volume":"51","author":"Finch","year":"1996","journal-title":"Drugs"},{"key":"key-10.1136\/bjophthalmol-2015-307722-59","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0303-8467(01)00180-9","article-title":"Successful treatment of ventriculostomy-related meningitis caused by vancomycin-resistant Enterococcus with intravenous and intraventricular quinupristin\/dalfopristin","volume":"104","author":"Williamson","year":"2002","journal-title":"Clin Neurol Neurosurg"},{"key":"key-10.1136\/bjophthalmol-2015-307722-60","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1046\/j.1469-0691.2000.00152.x","article-title":"In vitro activity of quinupristin\/dalfopristin in comparison with five antibiotics against worldwide clinical isolates of staphylococci","volume":"6","author":"Auckenthaler","year":"2000","journal-title":"Clin Microbiol Infect"},{"issue":"A)","key":"key-10.1136\/bjophthalmol-2015-307722-61","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/jac\/39.suppl_1.63","article-title":"Synergic activity of vancomycin-quinupristin\/dalfopristin combination against Enterococcus faecium","volume":"39","author":"Lorian","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"key-10.1136\/bjophthalmol-2015-307722-62","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/IIO.0b013e31822d67c7","article-title":"Vancomycin resistance in ocular infections","volume":"51","author":"Gupta","year":"2011","journal-title":"Int Ophthalmol Clin"},{"key":"key-10.1136\/bjophthalmol-2015-307722-63","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3109\/15569527.2012.759957","article-title":"Comparison of intravitreal vancomycin and daptomycin application in experimental methicillin-resistant Staphylococcus aureus (MRSA) endophthalmitis in rabbits","volume":"32","author":"Coskun","year":"2013","journal-title":"Cutan Ocul Toxicol"},{"key":"key-10.1136\/bjophthalmol-2015-307722-64","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1001\/archophthalmol.2011.2527","article-title":"Intravitreal daptomycin in a case of bilateral endogenous endophthalmitis","volume":"130","author":"Buzzacco","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307722-65","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1089\/jop.2012.0111","article-title":"Ocular penetration of topically applied 1% daptomycin in a rabbit model","volume":"29","author":"Sakarya","year":"2013","journal-title":"J Ocul Pharmacol Ther"},{"key":"key-10.1136\/bjophthalmol-2015-307722-66","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1007\/s00417-014-2784-2","article-title":"Pharmacokinetics of intravenously administered tigecycline in eye compartments: an experimental study","volume":"252","author":"Ozcimen","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307722-67","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1179\/1120009X12Z.00000000018","article-title":"Intravitreal tigecycline treatment in experimental Acinetobacter baumannii endophthalmitis","volume":"24","author":"Horozoglu","year":"2012","journal-title":"J Chemother"},{"key":"key-10.1136\/bjophthalmol-2015-307722-68","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1089\/jop.2014.0052","article-title":"New therapy option for treatment of methicillin-resistant Staphylococcus aureus keratitis: tigecycline","volume":"31","author":"Goktas","year":"2015","journal-title":"J Ocul Pharmacol Ther"},{"key":"key-10.1136\/bjophthalmol-2015-307722-69","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1128\/AAC.37.8.1563","article-title":"Genetics and mechanisms of glycopeptide resistance in enterococci","volume":"37","author":"Arthur","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.1136\/bjophthalmol-2015-307722-70","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1128\/CMR.13.4.686-707.2000","article-title":"Vancomycin-resistant enterococci","volume":"13","author":"Cetinkaya","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"key-10.1136\/bjophthalmol-2015-307722-71","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archophthalmol.2010.105","article-title":"Emerging vancomycin resistance: what are we waiting for?","volume":"128","author":"Jones","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307722-72","volume-title":"Antibiotic resistance threats in the United States, 2013","author":"Health","year":"2013"},{"key":"key-10.1136\/bjophthalmol-2015-307722-73","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.ajic.2015.06.028","article-title":"Decreasing vancomycin utilization in a neonatal intensive care unit","volume":"43","author":"Holzmann-Pazgal","year":"2015","journal-title":"Am J Infect Control"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2015-307722","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T08:51:54Z","timestamp":1601110314000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2015-307722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,23]]},"references-count":73,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,3,18]]},"published-print":{"date-parts":[[2016,4]]}},"alternative-id":["10.1136\/bjophthalmol-2015-307722"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2015-307722","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,23]]}}}